Abstract
The ethanol extract of Curculigo orchioides was evaluated for antiasthmatic activity by using various in vitro and in vivo animal models. In vitro models like isolated goat tracheal chain preparation and isolated guinea pig ileum preparation were studied to know basic mechanism by which extract shows relaxant activity. The study showed that extract is effective against histamine-induced contraction. In isolated goat tracheal chain preparation and isolated guinea pig ileum preparation extract exhibits maximum relaxant effect (p< 0.01) against histamine at concentrations 100μg/ml and 25μg/ml respectively. Animal studies involved use of histamine induced bronchoconstriction in guinea pigs, egg albumin induced passive paw anaphylaxis in rats and haloperidol-induced catalepsy in mice. These studies showed significant (p< 0.01) protection at lower doses while further increase in the dose level showed reduced activity. Biochemical estimations in milk-induced total leukocytes count and milk-induced differential leukocyte count were also studied. In this study there was maximum increase in leucocytes and lymphocytes (99%) and maximum decrease in eosinophils up to 0% at dose 375mg/kg p.o. body weight was observed. The results of these studies indicated usefulness of ethanol extract of Curculigo orchioides in asthma.
Keywords: Antiasthmatics, bronchoconstriction, Curculigo orchioides, eosinophils
Asthma is a very commonly occurring condition that is most difficult to control in chronic stage. In the United States alone, asthma affects almost 17 million people, and this is a 75% increase in the last 20 years. This means that about 1 out of every 20 adults and close to 1 out of 13 children today have asthma. An alarming fact is that since 1980, asthma in children under age 5 has risen remarkably. In school age children, asthma has risen by 75%. India alone has an estimated 15–20 million asthmatics. Mortality data from developed countries show that the rates varies from 0.1- 0.8 per 100,000 persons aged 5–341. For managing asthma attacks, symptomatic relief is foremost requirement. In India, in various traditional systems like Ayurveda, Unani and Siddha, numerous herbs were mentioned for therapeutic use in asthma. Curculigo orchioides Gaertn. is one of the important plant mentioned in Ayurveda and Unani for asthma2,3. In Chinese medicinal system also, Curculigo orchioides is one of the important plant. Its rhizomes were used as aphodisiac, alterative, appetizer, fattening; useful in piles, jaundice and colic disorders. Methanol extract has shown immunostimulant4, antioxidant5, hepatoprotective and antiinflammatory activity6.
Triterpenoides (Curculigol), glycosides (Curculignin A, B, C) curculigosaponin such as curculigenin A, B, C, corchicoside A, curculigoside B and alkaloids (Yuccagenin, Lycorin) are major components reported which might be responsible for various medicinal use of herb 7–17. Although, there is no scientific proof of the efficacy of plant extracts for antiasthmatic activity, the aim of this study was to evaluate antiasthmatic effect of Curculigo orchioides.
MATERIALS AND METHODS
Rhizomes of Curculigo orchioides were collected from local market of Pune, MS, India and were identified and authenticated from Agharkar Research Institute, Pune, India. The voucher specimen was deposited bearing no. AHMA- R-065. The collected material was air dried at 35–40° and pulverized in electric grinder. The powder obtained was extracted in ethanol by using Soxhlet extractor. The yield obtained was 6.45% w/w. Phytochemical screening reveled presence of phenolic compounds, flavanoids, tannins, glycosides, alkaloids saponnis and carbohydrates18. The extract was stored in a refrigerator for further use. Dunkon-Hartley Guinea pigs weighing 350–400g of either sex brought from National toxicological center Pune, Wistar rats weighing 150–250 g and Swiss mice of either sex bread at the Padmashree Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune were housed at standard conditions of temperature (22±1°) and 12/12 h light/dark cycle. They were fed with standard pellet diet (Amrut laboratory animal feed, Sangli, India) and had free access to water. Permission for conduct of these experiments was obtained from Institutional Animal Ethical Committee (IAEC). Toxicity studies conducted as per internationally accepted protocol drawn under OECD guidelines 420 in Swiss mice at a dose level of extracts up to 10 g/kg.
Isolated goat tracheal chain preparation19:
Isolated adult goat tracheal tissue was obtained from slaughter house. Trachea was cut into individual rings and tied together in series to form a chain. Trachea was suspended in bath of Kreb’s solution and was continuously aerated at 37±0.5°. Dose response curves of histamine in plain Kreb’s solution and in Kreb’s solution containing 100 μg/ml Curculigo orchioides extract were performed. Percent of maximum contractile responses were plotted to record dose response curves of histamine in the absence and presence of plant extract.
Isolated guinea pig ileum preparation20:
The guinea pigs (overnight fasted) were sacrificed and the ileum was mounted in an organ bath containing Tyrode solution, which was continuously aerated at 37±0.5°. Dose response curve of histamine in plain Tyrode solution and in Tyrode solution containing 25 μg/ml Curculigo orchioides extract were performed. Percentage maximum contractile response was plotted to generate dose response curve of histamine, in the absence and presence of the plant extract.
Histamine induced bronchoconstriction in guinea pigs21:
Duncon-Hartley Guinea pigs were divided into 8 groups (n=6), control group received saline and other groups received single dose of extract (75, 150, 200, 300, 600, 1200 mg/kg p.o.) respectively. Chlorpheniramine maleate (2 mg/kg) was used as positive control. Prior to and after drug treatment each animal was placed in the histamine chamber and exposed to 0.2% histamine aerosol. The preconvulsive time (PCT) was determined from the time of exposure to onset of dyspnoea leading to the appearance of preconvulsive dyspnoea in a min. The% protection offered by drugs in pCT 0 was calculated for each dose and positive control.
Haloperidol-induced catalepsy22:
Swiss mice were divided into 8 groups (n=6), control group received saline and other groups received single dose of extract (125, 250, 375, 500, 1000, 2000 mg/kg p.o.), respectively. chlorpheniramine maleate (10 mg/kg) was used as positive control. All the group received haloperidol (1 mg/kg i.p.) 1 h after the drug administration and the duration of catalepsy was measured at 0, 30, 60, 90, 120 and 150 min.
Passive paw anaphylaxis in rats23:
Wistar rats were given subcutaneously thee doses of 100 μg of egg albumin on d 1, 3 and 5. On day 10 of sensitization, blood was collected and centrifuged to separate serum. Animals were divided into eight groups (n=6). Control group received saline and other groups received single dose of extract 85, 175, 250, 350, 700, 1400 mg/kg p.o. Dexamethasone was used as standard (0.27 mg/kg p.o). Prior to drug treatment animals were sensitized with serum. Next 24 h, after drug treatment animals again challenged with 10 μg egg albumin and edema inhibition was calculated.
Milk-induced leucocytosis in mice24,25:
Swiss mice were divided into 8 groups (n=6), Control group received saline other groups received single dose of extract (125, 250, 375, 500, 1000, 2000 mg/kg p.o.), respectively. Only Milk received group served as an intoxicant. After 1 h of drug treatment except control all groups received boiled and cooled milk injection in dose of (4 ml/kg s.c.). Total leukocyte count was done in each group before drug administration and 24 h after milk injection.
RESULTS AND DISCUSSION
The present study dealt with screening of antiasthamatic activity of ethanol extract of rhizomes of Curculigo orchioides Gaertn. Bronchial asthma is a chronic inflammatory disease, characterized by both bronchoconstriction and airway inflammation which leads to bronchial hyper responsiveness to various stimuli, in which many cell types play a role, more important being mast cells, eosinophils and T-lymphocytes.
Different agonists like acetylcholine, histamine, 5-hydroxyltryptamine and bradykinin are responsible for contractile responces26. In isolated goat tracheal chain and isolated guinea pig ileum preparation, there is a right side shift of dose response curve of histamine in the presence of ethanol extract of Curculigo orchioides indicating antiasthmatic action (Table 1).
TABLE 1.
Dose of histamine | Isolated goat tracheal chain preparation | Isolated guinea pig ileum preparation | ||
---|---|---|---|---|
(2.5 μg/ml) | Control group | Test group | Control group | Test group |
(ml) | % Maximum contraction | % Maximum contraction | % Maximum contraction | % Maximum contraction |
0.1 | 25.758±2.579 | 14.386±1.162* | 17.776±0.925 | 12.058±1.188* |
0.2 | 51.074±3.971 | 28.418±1.874* | 31.748±0.501 | 22.534±1.618* |
0.4 | 72.278±1.790 | 44.91±2.968* | 63.488±2.511 | 43.806±2.163* |
0.8 | 89.822±1.291 | 54.731±3.010* | 93.33±2.988 | 59.682±2.952* |
1.6 | 91.578±2.444 | 63.856±5.564* | 93.33±2.988 | 64.446±1.384* |
Effect of the ethanol extract of Curculigo orchioides (co) on histamine-induced contraction on the isolated goat tracheal chain preparation and the isolated guinea pig ileum preparation was tabulated. All values are expressed as mean±SEM of a sample size of n=6; level of significance chosen was
p<0.05. All treated groups were compared with control group.
Histamine is one of the major inflammatory mediators in the immediate phase of asthma, causing airway hyper responsiveness and bronchial airway inflammation. The study regarding involvement of H1 and H2 receptors has been done in experimental asthma in guinea pig using respiratory smooth muscle and it was confirmed that there is prominent involvement of H1 receptors as compared to H2 receptors especially in asthama26.
The maximum percentage protection i.e. 90.11% observed at 200mg/kg dose for bronchorelaxant study comparable with that of standard chlorpheniramine maleate 91.92%. Statistical significance in post treated exposition time and mean exposition time also showed 200 mg/kg as effective (p< 0.01) dose. Further increase in the dose showed decreased activity (Table 2).
TABLE 2.
Groups | Dose in mg/kg p.o. | PCT (Before) T1 | PCT (After) T2 | Mean exposition time | % Protection |
---|---|---|---|---|---|
1 | Control | 1.488±0.104 | 1.504±0.187 | 0.076± 0.138 | 1.06 |
2 | 75 CO | 1.144±0.0314 | 2.67±0.237 | 1.526±0.2075* | 57.154 |
3 | 150 CO | 1.278±0.1044 | 3.436±0.187 | 2.158±0.138* | 62.81 |
4 | 200 CO | 1.258±0.0753 | 12.716±0.934 | 11.458±0.884* | 90.11 |
5 | 300 CO | 1.356±0.0532 | 5.58±0.240 | 4.232±0.264* | 75.734 |
6 | 600 CO | 1.432±.0519 | 4.208±0.306 | 2.776±0.3166* | 65.969 |
7 | 1200 CO | 1.29±0.152 | 1.382±0.088 | 0.272±0.0985 | 6.66 |
8 | CPM (2 mg/kg) | 1.308±0.1007 | 14.81±0.19 | 13.614±0.1607* | 91.92 |
All values are expressed as mean±SEM of a sample size of n=6; level of significance chosen was *p<0.05. All treated groups were compared with control group. CPM is chlorpheniramine maleate (2 mg/kg)
Haloperidol induces catalepsy by inhibiting dopamine D2 receptors and inhibits dopamine secretion. Dopamine is agonist for adrenaline. Adrenaline is physiological antagonist of histamine. So as there decrease in dopamine there is imbalance in neurotransmitters means high level of histamine27. In this study significant (p< 0.01) protection against haloperidol-induced catalepsy at dose 375 mg/kg. Further increase in the dose showed decreased activity (Table 3)
TABLE 3.
Group | Dose mg/kg | Duration of catalepsy (sec) at Mean±SEM | ||||
---|---|---|---|---|---|---|
30 min | 60 min | 90 min | 120 min | 150 min | ||
1 | Control | 236.66±12.82 | 273.66±8.42 | 285.33±4.72 | 299.66±0.33 | 238.66±12.96 |
2 | 125 CO | 226.00±0.68 | 254.5±2.21 | 234.0±1.34* | 249.0±0.85* | 225.6±1.563 |
3 | 250 CO | 219.33±2.246 | 248.0±1.25* | 218.50±2.2* | 228.5±2.87* | 210.0±2.14* |
4 | 375 CO | 112.0±4.93* | 93.0±1.96* | 70.83±2.76* | 52.83±2.92* | 72.0±1.88* |
5 | 500 CO | 190.1±13.5* | 227.33±8.7* | 205.0±10.3 | 208.0±5.2* | 200.83±3.7* |
6 | 1000 CO | 219.6±7.1 | 236.3±9.68* | 214.16±2.0* | 228.6±7.9* | 212.0±0.774 |
7 | 2000 CO | 223.8±1.1 | 255.6±3.93 | 239.6±7.14* | 246.6±0.84* | 228.6±4.28 |
8 | CPM (10 mg/kg) | 99.16±5.68* | 76.5±3.53* | 62.16±2.71* | 42.83±1.93* | 63.5±4.87* |
All values are expressed as mean±SEM of a sample size of n=6; level of significance chosen was * p<0.05. All treated groups were compared with control group. CPM is chlorpheniramine maleate (2 mg/kg)
Allergic asthama is a chronic inflammatory process occurring due to exposure of allergen resulting in the activation of T-lymphocyte with subsequent release of inflammatory mediators. Immuno-modulating agents are useful in the treatment of asthma by inhibiting the antigen-antibody (AG-AB) reaction and there by inhibiting the release of inflammatory mediators27. Curculigo orchioides has been reported to possess antiinflammatory activity6. Percent inhibition of paw edema volume was calculated and maximum effective dose was observed at 250 mg/kg. at different hour intervals it was found that effect of dose 250 mg/kg was maximum up to 24 h, further percent inhibition goes on decreasing. But still that percent inhibition in paw edema was significantly effective as compare to other doses. Where as, in statistical analysis of paw edema volume it was observed that 250 mg/kg dose had significant (p< 0.01) effect comparable that with dexamethasone. Here also observed that further increase in dose decreased activity (Table 4).
TABLE 4.
Groups | Dose mg/kg | Paw Edema Volume (ml) Mean ± SEM | |||
---|---|---|---|---|---|
1 h | 2 h | 3 h | 4 h | ||
1 | Control | 0.90±0.0367 | 0.76±0.0396 | 0.63±0.0246 | 0.56±0.0178 |
2 | 85 CO | 0.59±0.0881* | 0.44±0.0779* | 0.38±0.0545* | 0.34±0.0386* |
3 | 175 CO | 0.75±0.0208* | 0.57±0.0195* | 0.44±0.0250* | 0.41±0.0255* |
4 | 250 CO | 0.54±0.0499* | 0.31±0.0478* | 0.33±0.0402* | 0.29±0.0418 |
5 | 350 CO | 0.63±0.0225* | 0.43±0.0155* | 0.47±0.0110* | 0.44±0.0129* |
6 | 700 CO | 0.61±0.0290* | 0.49±0.0184* | 0.50±0.108 | 0.47±0.0132 |
7 | 1400 CO | 0.64±0.5050* | 0.49±0.0292* | 0.53±0.0225 | 0.49±0.0251 |
8 | Dexamethasone (0.27 mg/kg) | 0.45±0.0348* | 0.27±0.0580* | 0.29±0.0572* | 0.25±0.0407* |
All values are expressed as mean±SEM of a sample size of n=6; level of significance chosen was *p<0.05. All treated groups were compared with control group. CPM is chlorpheniramine maleate (2 mg/kg)
Herbal formulations used in the treatment of asthma include some antistress herbs to enable adoption to stress since excessive stress or nervous debility may aggravate symptoms of asthma. The normalization effect of an adaptogen can be observed in milk-induced leukocytosis (increase in leukocyte count) after parentral administration of milk. In the milk induced leukocytes count, expected results were to decrease leukocyte count at 375 mg/kg. But result obtained was exactly opposite i.e. at the dose 375 mg/kg there is highest increase in leukocyte count. (Table 5)
TABLE 5.
Groups | Treatment | Number of leukocytes (Cu.mm.) | ||
---|---|---|---|---|
Before treatment | After treatment | Difference | ||
1 | Control (10 ml/kg saline) | 6230±312.49 | 6550±287.23 | 320±155.4 |
2 | CO 125 + Milk (4 ml/kg sc) | 7340±545.07 | 8380±452.38 | 1040±344.02* |
3 | CO 250 + Milk (4 ml/kg sc) | 5980±336.01 | 7270±410.51 | 1290±88.600* |
4 | CO 375 + Milk (4 ml/kg sc) | 6730±449.05 | 9680±538.89 | 3350±383.73* |
5 | CO 500 + Milk (4 ml/kg sc) | 7010±187.35 | 7270±1601.9 | 1880±308.06* |
6 | CO 1000 + Milk (4 ml/kg sc) | 5530±196.60 | 7110±201.49 | 1700±226.38* |
7 | CO 2000 + Milk (4 ml/kg sc) | 7400±135.09 | 8900±85.147 | 1500±130.38* |
8 | Saline (10ml/kg) + Milk (4 ml/kg sc) | 6470±494.62 | 11460±776.76 | 4990±658.48 ## |
All values are expressed as mean±SEM of a sample size of n=6; level of significance chosen was *p<0.05. All treated groups were compared with control group. CPM is chlorpheniramine maleate (2 mg/kg)
Most allergic and non-allergic asthmatics, including those with mild asthma, have bronchial eosinophilia and there is a significant association between eosinophil activation and asthma severity as well as bronchial hyper responsiveness25. Therefore differential leukocyte count was carried out for doses 125, 250, 375, 500, 1000, 2000 mg/kg p.o. body weight. The result showed significant (p <0.01) i.e. up to 0% decrease in eosinophils count at dose 250, 375, 500 mg/kg. But at dose 375 mg/kg there is tremendous i.e. up to 99% of lymphocytes count. (Table 6). It indicates that increased leukocyte count in total leucocytes count model, mainly due to increased lymphocyte (B and T cells) count.
TABLE 6.
Groups | Treatment | Differential Leukocyte Count (%) | ||
---|---|---|---|---|
Neutrophils | Lymphocytes | Eosinophils | ||
1 | Control | 06±0.707 | 88±1.342 | 02±0.3162 |
2 | CO 125 + Milk (4 ml/kg sc) | 05±0.316* | 93±1.140 | 02±0.4472* |
3 | CO 250 + Milk (4 ml/kg sc) | 05±0.447* | 95±0.632* | 00±0.0* |
4 | CO 375 + Milk (4 ml/kg sc) | 01±0.316* | 99±0.316* | 00±0.0* |
5 | CO 500 + Milk (4 ml/kg sc) | 03±0.316* | 97±0.707* | 00±0.0* |
6 | CO 1000 + Milk (4 ml/kg sc) | 29±1.304* | 70±1.844* | 01±0.3162* |
7 | CO 2000 + Milk (4 ml/kg sc) | 13±0.632* | 83±1.342* | 04±0.0 |
8 | Saline (10 ml/kg) + Milk (4 ml/kg sc) | 08±0.707 | 88±2.828 | 04±0.3162 |
All values are expressed as mean±SEM of a sample size of n=6; level of significance chosen was *p<0.05. All treated groups were compared with control group. CPM is chlorpheniramine maleate (2 mg/kg)
Drugs effective in asthma are mostly steroidal in nature. Curculigo orchioides extract contain steroidal nucleus in form of triterpenoides and various sapogenins and saponin glycosides. So antiasthmatic activity showed by Curculigo orchioides might be because of these chemical moieties.
REFERENCES
- 1.Nichols DJ, Longsworth FG. Prevalence of exercise-induced asthma in schoolchildren in Kingston, St. Andrew and St. Catherine, Jamaica. West Indian Med J. 1995;44:16–9. [PubMed] [Google Scholar]
- 2.Nadkarni KM. Indian Materia Medica. 3rd ed. Mumbai: Popular Prakashan Pvt Ltd; 1976. [Google Scholar]
- 3.Kiritikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Dehadun: International Book Distributors; 1999. [Google Scholar]
- 4.Bafna AR, Misha SH. Immunostimulatory Effect of Methanolic Extract of Curculigo orchioides on Immunosuppressed Mice. J Ethnopharmacol. 2005;6:1–4. doi: 10.1016/j.jep.2005.06.048. [DOI] [PubMed] [Google Scholar]
- 5.Bafna AR, Misha SH. In-vitro Antioxidant Activity of Methanolic Extract of Rhizomes of Curculigo orchioides. ARS Pharm. 2005;46:147–9. [Google Scholar]
- 6.Rao KS, Misha SH. Studies on Curculigo orchioides Gaertn. for Anti-inflammatory and Hepatoprotective Activities. Indian Drugs. 2004;33:20–5. [Google Scholar]
- 7.Garg SN, Misha LN. Corchioside and Orcinol Glycoside from Curculigo orchioides. Phytochemistry. 1989;28:1771–2. [Google Scholar]
- 8.Krishana Rao RV, Nazar Ali. Occurrence of both Sapogenin and Alkoloid Lycorine in Curculigo orchioides. Indian J Pharm Sci. 1978;8:104–5. [Google Scholar]
- 9.Kubo M, Nakanishi K. A New Phenolic Glucoside, Curculigoside from rhizomes of Curculigo orchioides. Planta medica. 1983;47:52–5. doi: 10.1055/s-2007-969949. [DOI] [PubMed] [Google Scholar]
- 10.Mehata BK, Gawarikar R. Characterization of Novel Triterpenoid from Curculigo orchioides Gaertn. Indian J Chem (Section B) 1991;30:986–9. [Google Scholar]
- 11.Mehata BK, Dubey A. 4-Acetyl-2-methoxy-5-methyltriacetone, a New Aliphatic Long-Chain Methoxyketone from Curculigo orchioides Roots. Indian J Chem (Section B) 1983;22:282–3. [Google Scholar]
- 12.Tiwari RD, Misra G. Structural Studies of the Constituent of Rhizomes of Curculigo orchioides. Planta Medica. 1976;29:291–4. doi: 10.1055/s-0028-1097665. [DOI] [PubMed] [Google Scholar]
- 13.The Wealth of India-A Dictionary of Indian Raw Material and Industrial Products. New Delhi: NISCAIR, CSIR; 2003. [Google Scholar]
- 14.Xu JP, Xu RS. Cycloartane-type Sapogenin and their Glycosides from Curculigo orchioides. Phytochemistry. 1992;31:2455–8. [Google Scholar]
- 15.Xu JP, Xu RS. Four New Cycloartane Saponins from Curculigo orchioides. Planta Medica. 1992;58:208–10. doi: 10.1055/s-2006-961431. [DOI] [PubMed] [Google Scholar]
- 16.Xu JP, Xu RS. Glycosides of a Cycloartane Sapogenin from Curculigo orchioides. Phytochemistry. 1992;31:233–6. [Google Scholar]
- 17.Xu JP, Xu RS. Phenyl Glycosides from Curculigo orchioides. Acta Pharmaceutics Sinica. 1992;27:353–7. [PubMed] [Google Scholar]
- 18.Xu Junping. Constituent of Curculigo orchioides Isolation and Characterization of Curculigo and Orcinol Glycosides. Zhongcaoyao. 1986;17:8–9. [Google Scholar]
- 19.Chaudhari KN, Lahiri C. Role of Goat Trachea for an Isolated Tracheal Chain Preparation. Indian J Pharmacol. 1974;6:149–51. [Google Scholar]
- 20.Vogel GH, Vogel WH. Drug Discovery and Evaluation. Berlin: Spinger Verlag; 1998. [Google Scholar]
- 21.Gokhale AB, Saraf MN. Bronchoprotective Effect of Ethanolic Extract of Tephosia purpurea in-vivo. Indian Drugs. 1996;37:346–7. [Google Scholar]
- 22.Sanberg PR. Haloperidol-induced Catalepsy is Mediated by Postsynaptic Dopamine Receptors. Nature. 1980;284:472–3. doi: 10.1038/284472a0. [DOI] [PubMed] [Google Scholar]
- 23.Mitra SK. Antiasthmatic and Antianaphylactic Effect of E-721B: A Herbal Formulation. Indian J Pharmacol. 1999;31:133–7. [Google Scholar]
- 24.Bhargava KP, Singh N. Antistress Activity of Ocimum sanctum (linn) Indian J Med Res. 1981;73:443–51. [PubMed] [Google Scholar]
- 25.Horn BR, Robin ED. Total Eosinophils Count in the Management of Bronchial Asthma. N Engl J Med. 1975;292:1152–5. doi: 10.1056/NEJM197505292922204. [DOI] [PubMed] [Google Scholar]
- 26.Gosh MN. Fundamental of Experimental Pharmacology. 2nd ed. Calcutta: Scientific Book Agency; 1984. [Google Scholar]
- 27.Tripathi KD. Essentials of Medical Pharmacology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers; 2003. [Google Scholar]